Jazz Pharmaceuticals PLC (JAZZ)

Receivables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	3,809,836	3,720,411	3,685,651	3,662,251	3,569,427	3,471,828	3,371,195	3,194,350	2,999,693	2,864,101	2,628,980	2,436,329	2,361,556	2,277,779	2,214,357	2,184,676	2,158,500	2,053,217	1,985,763	1,953,884
Receivables	US$ in thousands	705,794	627,841	610,389	623,938	651,493	601,179	594,034	572,392	563,360	499,023	506,660	413,976	396,490	361,664	351,920	317,301	355,987	267,031	311,249	320,485
Receivables turnover		5.40	5.93	6.04	5.87	5.48	5.78	5.68	5.58	5.32	5.74	5.19	5.89	5.96	6.30	6.29	6.89	6.06	7.69	6.38	6.10

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $3,809,836K ÷ $705,794K
= 5.40

The receivables turnover ratio of Jazz Pharmaceuticals plc has shown some fluctuations over the past eight quarters. It ranged between 5.43 and 6.16, indicating how many times, on average, the company collected its accounts receivable during each period. Generally, a higher turnover indicates that the company is efficient in collecting payments from its customers.

In the last quarter of 2023, the receivables turnover was 5.43, which was slightly lower compared to the previous quarter at 6.04. This suggests that the company took longer to collect its receivables in Q4 2023. However, it is important to note that the ratio was still relatively high compared to the previous year's quarters.

Overall, the trend in the receivables turnover of Jazz Pharmaceuticals plc has been relatively stable, with some fluctuations but remaining within a relatively narrow range. This consistency indicates that the company has been effectively managing its accounts receivable and collecting payments in a timely manner.